Payman Zamani

Has grant

Assistant Professor, Clinician-Educator

University of Pennsylvania

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Payman Zamani is an Assistant Professor and Clinician-Educator at the University of Pennsylvania, USA. His research primarily focuses on heart failure, with recent articles exploring topics such as skeletal muscle dysfunction, proteomics, and prognostic biomarkers. He is particularly interested in the relationships between exercise intolerance, heart function, and post-transplant survival outcomes.

Recent Grants

Grant: Close

HFpEF: more than just the heart - Why the mitochondria and capillaries matter

Open Date: 2016-02-10

Close Date: 2020-01-31

Articles (11)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (7)

Marie-Joe Dib

Imperial College London

UNITED KINGDOM

View details

Michael Genuardi

Assistant Professor of Clinical Medicine

University of Pennsylvania

UNITED STATES

View details

Mark Richards

Professor

National University of Singapore (NUS)

SINGAPORE

View details

Douglas Mann

Professor of Medicine

Washington University in Saint Louis School of Medicine

UNITED STATES

View details

Jordana B. Cohen

UNITED STATES

View details

J. Eduardo Rame

Louis R. Dinon MD Professor of Medicine, Enterprise Chief

Thomas Jefferson University

UNITED STATES

View details

MARIA VALERO-MUNOZ

Assistant Professor

Boston University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Payman Zamani

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (11)

Musclin Counteracts Skeletal Muscle Dysfunction and Exercise Intolerance in Heart Failure With Preserved Ejection Fraction

Prognostic Significance and Biologic Associations of Senescence‐Associated Secretory Phenotype Biomarkers in Heart Failure

Proteomic Associations of Adverse Outcomes in Human Heart Failure

Proteomic Associations of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) in Heart Failure With Preserved Ejection Fraction

Urinary Proteomics and Outcomes in Heart Failure With Preserved Ejection Fraction

Chronotropic Incompetence after Heart Transplantation Is Associated with Increased Mortality and Decreased Functional Capacity

Early Cardiopulmonary Fitness after Heart Transplantation as a Determinant of Post-Transplant Survival

Proteomic Analysis of Effects of Spironolactone in Heart Failure With Preserved Ejection Fraction

A Modified Grading System for Early Right Heart Failure Matches Functional Outcomes and Survival After Left Ventricular Assist Devices

Multimodality assessment of heart failure with preserved ejection fraction skeletal muscle reveals differences in the machinery of energy fuel metabolism

Clinical and Proteomic Correlates of Plasma ACE2 (Angiotensin-Converting Enzyme 2) in Human Heart Failure

Collaborators (7)

Marie-Joe Dib

Michael Genuardi

Mark Richards

Douglas Mann

Jordana B. Cohen

J. Eduardo Rame

MARIA VALERO-MUNOZ

Make your next move.